![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 30, 2017 6:03:04 PM
I strongly believe Pluristem is on the cusp of major market exposure - what's quite amazing (taking into account their revolutionary technology) is that Plauristem is still very much under the radar. I also believe that big pharma is watching Stem Cell companies very closely, as this technology could potentially make a large percentage of traditional drug treatment obsolete - this is where the issue of partnerships becomes very interesting, but, at the same time quite problematic for the drug industry.
All in all, Pluristem's proprietary 3D generating and manufacturing capability is a game changer - I'm hopeful this recent infusion of capital will accelerate their R&D, leading to significant breakthroughs near term!
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM